Intracranial Pressure Monitoring in Moderate Traumatic Brain Injury (IPMMTBI)

July 25, 2023 updated by: Tang-Du Hospital

A Multi-center Observational Cohort Study of Management of Moderate Traumatic Brain Injury With or Without Intracranial Pressure Monitoring in Patients With Moderate Traumatic Brain Injury in China

Objectives The primary focus for scientific investigation is to conduct a multi-center observational study to determine if intracranial pressure (ICP) monitoring to direct treatment of patients with moderate traumatic brain injury (TBI) improves medical practice and patient outcomes in China.

Design and Outcomes This is a prospective observational cohort multi-center study with blinded evaluation of outcome. It is a 2-group design. Neurologic outcome is evaluated by extended Glasgow outcome score(GOSE) at 6 months.

Interventions and Duration This is an observational study. The decision of intracranial pressure monitoring is made by the relatives of patient. Management of all patients will be consistent with protocols presently being used in the study hospitals. For patients who received ICP monitoring, the management will also be based specifically on the presence of intracranial hypertension. Each patient will be evaluated at 6 months post injury on neurological outcomes.

Sample Size and Population 832 patients with moderate traumatic brain injury will be collected on this study.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

832

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Zhihong Li, Doctor
  • Phone Number: +81-029-84717821
  • Email: 409615390@qq.com

Study Locations

    • Shannxi Province
      • Xi'an, Shannxi Province, China
        • Recruiting
        • Tangdu Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 73 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patient with acute moderate traumatic brain injury

Description

Inclusion Criteria:

  • History of head trauma
  • 18 ≤ age ≤ 70 years
  • Abnormal head CT scan (skull fracture, intracranial hematoma, brain contusion, cerebral infarction, brain edema, hydrocephalus, etc.)
  • Glasgow coma scale at admission: 9-12
  • Arriving at hospital within 24 hours after injury
  • Systolic blood pressure ≥100 millimeter of mercury
  • No pregnant

Exclusion Criteria:

  • Refusing follow up visit
  • Penetrating head injury, spine or spinal cord injury
  • Surgical treatment in other hospital before admission
  • Cardiopulmonary resuscitation after injury or in need of blood transfusion due to active bleeding
  • Consciousness disorder caused not by head trauma (alcoholism, drug overdose, etc.)
  • Prior history of head trauma or stroke
  • Multiple injuries, with severity score of other parts>18
  • Rhabdomyolysis, with blood creatine kinase (CK)>5000 international unit/L
  • Injury of aorta, carotid artery or vertebral artery
  • Serum creatinine (female)>1.2mg/dL (106μmol/L), serum creatinine (male)>1.5mg/dL (133μmol/L)
  • Glomerular filtration rate (eGFR) <60 milliliter/min
  • Body mass index (BMI) <18.5kg/m2 or >40kg/m2
  • Estimated survival time less than 1 year
  • Participating in other on-going clinical researches
  • Other systemic diseases: uremia, liver cirrhosis, malignant tumor, mental illness, drug, or alcohol dependence, etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ICP monitoring group
patients received ICP monitoring
An invasive method to monitor the intracranial pressure of patient
conventional treatment group
patients without ICP monitoring and received conventional treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Good neurologic outcome
Time Frame: Within 6 months after traumatic brain injury
The proportion of patients with good neurological outcomes (GOSE: 5-8) in each group at 6 months after traumatic brain injury
Within 6 months after traumatic brain injury

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6 months mortality
Time Frame: Within 6 months after traumatic brain injury
The mortality of patients in each group at 6 months after traumatic brain injury
Within 6 months after traumatic brain injury
In-hospital mortality
Time Frame: Within 1 month after traumatic brain injury
The mortality of patients in each group during hospitalization
Within 1 month after traumatic brain injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2021

Primary Completion (Estimated)

December 31, 2023

Study Completion (Estimated)

June 30, 2024

Study Registration Dates

First Submitted

April 7, 2021

First Submitted That Met QC Criteria

May 23, 2021

First Posted (Actual)

May 25, 2021

Study Record Updates

Last Update Posted (Actual)

July 27, 2023

Last Update Submitted That Met QC Criteria

July 25, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Moderate Traumatic Brain Injury

Clinical Trials on Intracranial pressure monitoring

3
Subscribe